(Q33836692)

29 July 2017

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis (English)

1 reference

29 July 2017

0 references

1 reference

Sandeep Tyagi

1

1 reference

29 July 2017

E Nuermberger

2

1 reference

29 July 2017

T Yoshimatsu

3

1 reference

29 July 2017

K Williams

4

1 reference

29 July 2017

I Rosenthal

5

1 reference

29 July 2017

N Lounis

6

1 reference

29 July 2017

W Bishai

7

1 reference

29 July 2017

J Grosset

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

49

1 reference

29 July 2017

6

1 reference

29 July 2017

2289-2293

1 reference

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Bioavailability of rifampin in experimental murine tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

Antibiotic-dependent correlation between drug-induced killing and loss of luminescence in Streptococcus gordonii expressing luciferase.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140529

A selective oleic acid albumin agar medium for tubercle bacilli

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15917523

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.49.6.2289-2293.2005

1 reference

29 July 2017

1 reference

29 July 2017

1 reference